If you have noticed a family member or close friend struggling with memory loss, frequently asking the same questions, telling the same story, or suffering from mood swings, they could be suffering from cognitive impairment.
It’s important to know that cognitive impairment is a wide umbrella and doesn’t necessarily mean your loved one is heading toward debilitating disease or losing the ability to take care of themselves. Getting treatment from medical professionals who are trained to treat cognitive impairment is crucial.
A study by the National Institutes of Health the ApoE4 allele represents a critical risk factor for Alzheimer’s Disease. Dr. Berislav Zlokovic, M.D., Ph.D., who led the study, said “Understanding the role of ApoE4 in Alzheimer’s disease may be one of the most important avenues to a new therapy.”
The Centers for Disease Control also cites age as another significant risk factor for cognitive impairment and related diseases. We’re living in an era where one of the largest segments of our population—the Baby Boomers—is rapidly reaching retirement age. The CDC reports there are already 5.1 million people age 65 or older living with Alzheimer’s disease, which is the most common form of cognitive impairment. And that number could more than double in the next 30 years.
Dr. Dale Bredesen is on the front line fighting cognitive impairment, especially Alzheimer’s disease. He has developed a protocol that uses advanced testing, targeted medical interventions – including hormone support, immune regulation and detoxification – combined with specific dietary and lifestyle optimization to help dramatically reverse cognitive decline.
Our Dr. Lawson has earned certification in the Bredesen Protocol, and we are proud to offer its elements to our patients with our Brain Health Optimization (BHO) Evaluation and Treatment program. Dr. Lawson is passionate about helping patients with all types and levels of cognitive impairment fight for a better quality of life.
Patients can expect a comprehensive consultation, physical examination, and an assessment to achieve the best results.
Our Comprehensive Initial Brain Health Assessment consists of as many as 11 tests, which are then summarized in a report we call the “Cognoscopy.” It brings together all of the findings, and summarizes risks for each of the six types of Alzheimer’s disease. It also includes a clinical plan to optimize health and reverse mild cognitive decline if it has begun.
Our initial evaluation and treatment includes:
- Part 1: 2-hour in-office consultation to review core test results.
- Part 2: Physical examination (usually on same day as part 1).
- Part 3: Baseline cognitive assessment (typically on same day as part 1).
- Part 4: 1.5-hour additional consultation (day 2 or later depending on availability of test results). This appointment can be in office or via tele-video.
You can enroll online or give us a call to discuss your specific circumstances and receive the best direction toward action and improvement.